Savara Inc. has grown revenue −14% a year over three years. Revenue growth, 3-year annual rate: −14% (Biotechnology median +21%). Years of annual history on file: 29, FY1997 to FY2025, as filed.

SVRASavara Inc.

HealthcareUSD

$5.62

$2.5852 weeks$6.94

Is it growing?

Is SVRA growing?

Savara Inc. has grown revenue −14% a year over three years.

−14%

Revenue growth, 3-year annual rate · Biotechnology median +21% · shrinking · compounded from fiscal-year columns as filed

Years of annual history on file: 29
Years of annual history on file · FY1997 to FY2025, as filed

Annual income statements as filed with the SEC.

Biotechnology

Ranks #103 of 145 by Smart Score

Hemab Therapeutics Holdings, Inc.

IMTX-4.9%

Immatics N.V.

JBIO-0.41%

Jade Biosciences, Inc.

EYPT-4.8%

EyePoint, Inc.